INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Most active filers · 30d

  1. 01FWFogarty Patrick W0B / 206S206 trades$1.10M
  2. 02Kurtz George0B / 179S179 trades$43.30M
  3. 03SPSaba Capital Management, L.P.66B / 17S · 11 late83 trades$22.10M
  4. 04NYNissan Yitzhak82B / 0S · 79 late82 trades$2.61M
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SJSheena Jonathan0B / 37S37 trades$1.72M
  8. 08CMCannon-Brookes Michael35B / 0S35 trades$11.72M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10ABAndreas Bechtolsheim0B / 33S33 trades$143.06M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. BUYMTDRMatador Resources CoNov 5 – Nov 189 insiders$1.02M
  3. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  4. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  5. SELLMGNIMAGNITE, INC.Nov 5 – Nov 198 insiders$2.81M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

74,191 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
CL
Caldwell Jonathan L.Chief People Officer
VVVVALVOLINE INC
Tax withholding
F$5,824
186 sh
Nov 28, 2025Dec 1, 2025
Page 1730 of 1855
← PrevNext →
traded Nov 28, 2025
+3d
SEC Form 4

Evidence

9
HE
Huckins Scott E.Director, President and CEO
REYNReynolds Consumer Products Inc.
Option exercise
M—
18.9K sh
Dec 1, 2025Dec 1, 2025
traded Dec 1, 2025
+0dSEC Form 4

Evidence

9
HT
Hamilton Brian TDirector, President of CCBX
CCBCOASTAL FINANCIAL CORP
Tax withholding
F$26K
232 sh
Nov 28, 2025Dec 1, 2025
traded Nov 28, 2025
+3dSEC Form 4

Evidence

9
MM
Morrell MarthaCHIEF MEDICAL OFFICER
NPCENeuroPace Inc
Tax withholding
F$5,891
357 sh
Nov 27, 2025Dec 1, 2025
traded Nov 27, 2025
+4dSEC Form 4

Evidence

9
CL
Caldwell Jonathan L.Chief People Officer
VVVVALVOLINE INC
Option exercise
M—
595 sh
Nov 28, 2025Dec 1, 2025
traded Nov 28, 2025
+3dSEC Form 4

Evidence

9
GC
Gantt Greg CDirector
ODFLOLD DOMINION FREIGHT LINE, INC.
Option exercise
M—
489 sh
Dec 1, 2025Dec 1, 2025
traded Dec 1, 2025
+0dSEC Form 4

Evidence

9
GC
Gantt Greg CDirector
ODFLOLD DOMINION FREIGHT LINE, INC.
Option exercise
M—
338 sh
Dec 1, 2025Dec 1, 2025
traded Dec 1, 2025
+0dSEC Form 4

Evidence

9
LG
Lepore Dawn GDirector
LDIloanDepot, Inc.
Option exercise
M—
24.6K sh
Nov 28, 2025Dec 1, 2025
traded Nov 28, 2025
+3dSEC Form 4

Evidence

9
SD
Sturgeon DioneChief Accounting Officer
VVVVALVOLINE INC
Option exercise
M—
398 sh
Nov 28, 2025Dec 1, 2025
traded Nov 28, 2025
+3dSEC Form 4

Evidence

9
PG
Pcp Managers Gp, LlcDirector, 10% Owner
LDIloanDepot, Inc.
Option exercise
M—
49.2K sh
Nov 28, 2025Dec 1, 2025
traded Nov 28, 2025
+3dSEC Form 4

Evidence

9
HC
Hicks Ken CDirector
ASOAcademy Sports & Outdoors, Inc.
Option exercise
M—
1,245 sh
Nov 30, 2025Dec 1, 2025
traded Nov 30, 2025
+1dSEC Form 4

Evidence

9
FL
Fulcher LinneChief Operating Officer
VVVVALVOLINE INC
Tax withholding
F$7,608
243 sh
Nov 28, 2025Dec 1, 2025
traded Nov 28, 2025
+3dSEC Form 4

Evidence

9
Brown EthanPresident, Chief Exec. Officer
BYNDBEYOND MEAT, INC.
Tax withholding
F$1,939
1,975 sh
Nov 28, 2025Dec 1, 2025
traded Nov 28, 2025
+3dSEC Form 4

Evidence

9
AD
Ajami DariushChief Innovation Officer
BYNDBEYOND MEAT, INC.
Tax withholding
F$463
472 sh
Nov 28, 2025Dec 1, 2025
traded Nov 28, 2025
+3dSEC Form 4

Evidence

9
CL
Caldwell Jonathan L.Chief People Officer
VVVVALVOLINE INC
Option exercise
M—
595 sh
Nov 28, 2025Dec 1, 2025
traded Nov 28, 2025
+3dSEC Form 4

Evidence

9
GC
Gantt Greg CDirector
ODFLOLD DOMINION FREIGHT LINE, INC.
Option exercise
M—
489 sh
Dec 1, 2025Dec 1, 2025
traded Dec 1, 2025
+0dSEC Form 4

Evidence

9
GP
Guerre Robert PaulSec, Dir of Corp Compliance
UFPIUFP INDUSTRIES INC
Grant or award
A$1,395
15 sh
Nov 28, 2025Dec 1, 2025
traded Nov 28, 2025
+3dSEC Form 4

Evidence

9
HA
Hess AndrewDirector, CFO
KNXKnight-Swift Transportation Holdings Inc.
Grant or award
A—
8,733 sh
Nov 28, 2025Dec 1, 2025
traded Nov 28, 2025
+3dSEC Form 4

Evidence

9
GC
Gantt Greg CDirector
ODFLOLD DOMINION FREIGHT LINE, INC.
Option exercise
M—
708 sh
Dec 1, 2025Dec 1, 2025
traded Dec 1, 2025
+0dSEC Form 4

Evidence

8
GY
Greenstreet YvonneDirector, Chief Executive Officer
ALNYALNYLAM PHARMACEUTICALS, INC.
Option exercise
M—
659 sh
Nov 26, 2025Dec 1, 2025
traded Nov 26, 2025
+5dSEC Form 4

Evidence

8
GY
Greenstreet YvonneDirector, Chief Executive Officer
ALNYALNYLAM PHARMACEUTICALS, INC.
Option exercise
M—
839 sh
Nov 26, 2025Dec 1, 2025
traded Nov 26, 2025
+5dSEC Form 4

Evidence

8
BJ
Burth JonathanChief Operating Officer
COCOVita Coco Company, Inc.
Tax withholding
F$87K
1,614 sh
Nov 27, 2025Dec 1, 2025
traded Nov 27, 2025
+4dSEC Form 4

Evidence

8
GY
Greenstreet YvonneDirector, Chief Executive Officer
ALNYALNYLAM PHARMACEUTICALS, INC.
Option exercise
M—
2,352 sh
Nov 26, 2025Dec 1, 2025
traded Nov 26, 2025
+5dSEC Form 4

Evidence

8
GY
Greenstreet YvonneDirector, Chief Executive Officer
ALNYALNYLAM PHARMACEUTICALS, INC.
Option exercise
M—
847 sh
Nov 26, 2025Dec 1, 2025
traded Nov 26, 2025
+5dSEC Form 4

Evidence

7
AT
Arora TarunChief Accounting Officer
RNGRingCentral, Inc.
Open-market sale · 10b5-1 plan
SELL$26K
942 sh
Nov 26, 2025Dec 1, 2025
traded Nov 26, 2025
+5dSEC Form 4

Evidence

5
FA
Flees Lori AnnDirector, President & CEO
VVVVALVOLINE INC
Tax withholding
F$38K
1,219 sh
Nov 28, 2025Dec 1, 2025
traded Nov 28, 2025
+3dSEC Form 4

Evidence

5
FA
Flees Lori AnnDirector, President & CEO
VVVVALVOLINE INC
Option exercise
M—
2,643 sh
Nov 28, 2025Dec 1, 2025
traded Nov 28, 2025
+3dSEC Form 4

Evidence

5
FA
Flees Lori AnnDirector, President & CEO
VVVVALVOLINE INC
Grant or award
A$1,785
57 sh
Nov 28, 2025Dec 1, 2025
traded Nov 28, 2025
+3dSEC Form 4

Evidence

5
FA
Flees Lori AnnDirector, President & CEO
VVVVALVOLINE INC
Option exercise
M—
2,643 sh
Nov 28, 2025Dec 1, 2025
traded Nov 28, 2025
+3dSEC Form 4

Evidence

5
SG
Schneider Terrence G.VP, SUPPLY CHAIN
DGIIDIGI INTERNATIONAL INC
Tax withholding
F$31K
732 sh
Nov 30, 2025Dec 1, 2025
traded Nov 30, 2025
+1dSEC Form 4

Evidence

5
SG
Schneider Terrence G.VP, SUPPLY CHAIN
DGIIDIGI INTERNATIONAL INC
Tax withholding
F$24K
575 sh
Nov 29, 2025Dec 1, 2025
traded Nov 29, 2025
+2dSEC Form 4

Evidence

4
SF
Simon FredericDirector
FROGJFrog Ltd
Gift · 10b5-1 plan
G—
47.0K sh
Nov 26, 2025Dec 1, 2025
traded Nov 26, 2025
+5dSEC Form 4

Evidence

4
AT
Arora TarunChief Accounting Officer
RNGRingCentral, Inc.
Open-market sale · 10b5-1 plan
SELL$112K
3,888 sh
Dec 1, 2025Dec 1, 2025
traded Dec 1, 2025
+0dSEC Form 4

Evidence

4
WC
Wren ChrisVP of Operations
PLNHPlanet 13 Holdings Inc.
Open-market sale · 10b5-1 plan
SELL$12K
61.6K sh
Nov 25, 2025Dec 1, 2025
traded Nov 25, 2025
+6dSEC Form 4

Evidence

1
BM
Berman David MHEAD OF R&D
IMCRImmunocore Holdings plc
Option exercise · 10b5-1 plan
M—
69.4K sh
Nov 26, 2025Dec 1, 2025
traded Nov 26, 2025
+5dSEC Form 4

Evidence

1
TE
Tessari EbenCHIEF OPERATING OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Option exercise · 10b5-1 plan
M$4,578
200 sh
Nov 26, 2025Dec 1, 2025
traded Nov 26, 2025
+5dSEC Form 4

Evidence

1
TE
Tessari EbenCHIEF OPERATING OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Option exercise · 10b5-1 plan
M—
200 sh
Nov 26, 2025Dec 1, 2025
traded Nov 26, 2025
+5dSEC Form 4

Evidence

0
DB
Dageville BenoitDirector, Founder and Chief Architect
SNOWSnowflake Inc.
Option exercise · 10b5-1 plan
M—
25.0K sh
Nov 28, 2025Dec 1, 2025
traded Nov 28, 2025
+3dSEC Form 4

Evidence

0
DB
Dageville BenoitDirector, Founder and Chief Architect
SNOWSnowflake Inc.
Gift · 10b5-1 plan
G—
7,500 sh
Nov 28, 2025Dec 1, 2025
traded Nov 28, 2025
+3dSEC Form 4

Evidence

0
BM
Berman David MHEAD OF R&D
IMCRImmunocore Holdings plc
Option exercise · 10b5-1 plan
M—
5,521 sh
Nov 28, 2025Dec 1, 2025
traded Nov 28, 2025
+3dSEC Form 4

Evidence